Target intelligence / Profile preview

Glutamate ionotropic receptor kainate type (KAR) (KAR)

Target
KAR
Molecular classification
Ion channel, Ligand-gated ion channel, Glutamate receptor, Receptor
01

Overview

The glutamate ionotropic receptor kainate type (KAR) is a class of ligand-gated ion channels that mediate excitatory neurotransmission in the central nervous system (UniProt: P39086). Composed of various combinations of five subunits (GluK1-GluK5), these receptors are distinct from AMPA and NMDA receptors in their kinetics and physiological roles (Lerma & Marques, Neuron, 2013). KARs function both postsynaptically to mediate excitatory currents and presynaptically to modulate the release of other neurotransmitters like GABA and glutamate (IUPHAR/BPS Guide to Pharmacology, 2023). They play a critical role in synaptic plasticity and the regulation of neuronal circuit excitability. Dysregulation of KAR signaling is implicated in several neurological and psychiatric conditions, including epilepsy, neuropathic pain, and schizophrenia (Jane et al., British Journal of Pharmacology, 2009). Consequently, KARs are significant therapeutic targets, with research focusing on subunit-specific antagonists to treat hyperexcitability disorders without the side effects associated with broad-spectrum glutamate inhibition (StatPearls, 2023).

Other names
Kainate receptoriGluRGRIKIonotropic glutamate receptor kainate typeGRIK1GRIK2GRIK3GRIK4GRIK5
02

Mechanism of action

Ligand-gated ion channel activation or inhibition; drugs act as agonists, antagonists, or non-competitive modulators to regulate cation flux (Na+ and K+) across the neuronal membrane (IUPHAR/BPS Guide to Pharmacology, 2023).

03

Biological functions

Excitatory neurotransmissionSynaptic plasticityPresynaptic modulationSignal transduction
04

Disease associations

EpilepsyNeuropathic painSchizophreniaBipolar disorderNeurodegenerative diseaseDepression
05

Safety considerations

ExcitotoxicityPro-convulsant effectsCognitive impairmentSedation
06

Interacting drugs

Kainic acid

5 more in the full profile.

07

Biomarkers

GRIK1 gene expressionGRIK2 gene polymorphismGlutamate levels in cerebrospinal fluid

Beyond the preview

Go deeper on Glutamate ionotropic receptor kainate type (KAR) (KAR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glutamate ionotropic receptor kainate type (KAR) (KAR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call